MKS Instruments Inc
XMUN:MKT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
MKS Instruments Inc
XMUN:MKT
|
US |
|
Biogaia AB
F:BGL
|
SE |
|
N
|
Novartis AG
XMUN:NOT
|
CH |
|
Biogaia AB
F:BGLA
|
SE |
|
XSpray Pharma AB (publ)
F:6XP
|
SE |
Wall St Price Targets
MKT Price Targets Summary
MKS Instruments Inc
According to Wall Street analysts, the average 1-year price target for MKT is 274.2 EUR with a low forecast of 183.74 EUR and a high forecast of 382.03 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MKT's stock price target?
Price Target
274.2
EUR
According to Wall Street analysts, the average 1-year price target for MKT is 274.2 EUR with a low forecast of 183.74 EUR and a high forecast of 382.03 EUR.
What is the Revenue forecast for MKS Instruments Inc?
Projected CAGR
12%
Over the last 14 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 3 years is 12%.
What is the Operating Income forecast for MKS Instruments Inc?
Projected CAGR
31%
Over the last 14 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 3 years is 31%.
What is the Net Income forecast for MKS Instruments Inc?
Projected CAGR
47%
Over the last 14 years, the compound annual growth rate for Net Income has been 6%. The projected CAGR for the next 3 years is 47%.
